Genetic considerations for adults with congenital heart disease

Seiji Ito1, Kimberly A Chapman2, Monisha Kisling2

  • 1Division of Pediatric Cardiology, Children's National Health System, Washington, District of Columbia.

Insights

Congenital heart disease (CHD) affects about 1% of newborns and is increasingly seen in adults due to better medical care. Understanding the genetic causes of CHD is crucial for counseling and future personalized treatments.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Congenital heart disease (CHD) is the most common birth defect, affecting approximately 1% of all births.
  • Advances in medical care have led to a growing population of adults with CHD, with survival rates exceeding 90% into adulthood.
  • The genetic underpinnings of CHD are complex, including chromosomal abnormalities and single gene mutations, yet the etiology remains unknown in 70-80% of cases.

Purpose of the Study:

  • To highlight the increasing importance of genetics in the care of adult congenital heart disease (CHD) patients.
  • To emphasize the need for genetic counseling for adults with CHD to understand disease etiology and recurrence risks.
  • To advocate for a multidisciplinary approach in managing adult CHD patients.

Main Methods:

  • Review of current literature on the genetic causes of CHD.
  • Discussion of the role of genetic counseling in adult CHD care.
  • Exploration of emerging precision medicine approaches.

Main Results:

  • Genetic factors contribute significantly to CHD, with categories including chromosomal aneuploidy, deletions/duplications, single gene mutations, and copy number variations.
  • A substantial proportion of CHD cases lack a defined etiology, underscoring the need for further genetic research.
  • Genetic counseling is becoming increasingly vital for adult CHD patients and their families.

Conclusions:

  • The role of genetics in adult CHD is expanding, necessitating specialized genetic counseling.
  • A multidisciplinary approach integrating genetic expertise is essential for comprehensive adult CHD care.
  • Precision medicine holds promise for individualized therapies in the management of adult CHD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
304
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
252
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.3K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
614
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K